Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
Clinical trial NCT01107938 · UNKNOWN
Trial details
- NCT number
- NCT01107938
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2010-06-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.